MANUFACTURER: BioCryst Pharmaceuticals
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Orladeyo is a prescription medication used to prevent attacks of hereditary angioedema in adults and children by reducing the frequency of attacks. It is a subcutaneous injection that works by inhibiting kallikrein, an enzyme involved in the production of bradykinin.
